Form 4: Amgen SVP & CCO Nancy Grygiel Reports Changes in Beneficial Ownership

Nancy Grygiel, SVP & CCO of Amgen, reports the disposition of common stock due to tax withholding related to vested restricted stock units.

Summary

• Nancy Grygiel, a Senior Vice President and Chief Commercial Officer at Amgen Inc., filed a Form 4 on May 2, 2025, reporting changes in her beneficial ownership of Amgen common stock.
• The reported transactions involve the disposition of shares to cover tax obligations related to the vesting of restricted stock units (RSUs).
• Specifically, 118 shares were disposed of at a price of $283.78, and another 111 shares were disposed of at the same price.
• Following these transactions, Grygiel directly owns 7,983 shares of Amgen common stock.
• She also indirectly owns 102.9274 shares through the company's 401(k) plan.
• The filing also mentions dividend equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan, which are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to stock transactions for tax purposes, so it doesn't significantly impact sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates

Keywords

Form 4, Beneficial Ownership, Amgen, AMGN, Nancy Grygiel, CCO, SVP, Stock Disposition, 401(k), Dividend Equivalents, RSUs